Serum Oxidative and Nitrosative Stress Markers in Clear Cell Renal Cell Carcinoma
暂无分享,去创建一个
Mateusz Mołoń | Marek Biesiadecki | Krzysztof Balawender | Sabina Galiniak | K. Balawender | Patrycja Olech
[1] S. Galiniak,et al. Oxidative Stress Markers in Urine and Serum of Patients with Bladder Cancer , 2023, Antioxidants.
[2] M. Tretiakova. What’s new in kidney tumor pathology 2022: WHO 5th edition updates , 2022, Journal of pathology and translational medicine.
[3] K. Izumi,et al. Epidemiology and Prevention of Renal Cell Carcinoma , 2022, Cancers.
[4] Zhe Zhang,et al. Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress , 2022, Antioxidants.
[5] A. Verim,et al. Evaluation of advanced protein oxidation and RAGE gene variants in the risk of laryngeal cancer , 2022, Biotechnology & Biotechnological Equipment.
[6] J. Raman,et al. Incidence and Distribution of New Renal Cell Carcinoma Cases: 27-Year Trends from a Statewide Cancer Registry , 2022, Journal of kidney cancer and VHL.
[7] C. Costagliola,et al. Free Radical Properties, Source and Targets, Antioxidant Consumption and Health , 2022, Oxygen.
[8] Kwang-Won Lee,et al. Methylglyoxal-Derived Advanced Glycation End Products (AGE4) Promote Cell Proliferation and Survival in Renal Cell Carcinoma Cells through the RAGE/Akt/ERK Signaling Pathways. , 2021, Biological & pharmaceutical bulletin.
[9] Guangzhen Wu,et al. The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC , 2021, Frontiers in Oncology.
[10] J. Kamińska,et al. Association of Tumour Microenvironment with Protein Glycooxidation, DNA Damage, and Nitrosative Stress in Colorectal Cancer , 2021, Cancer management and research.
[11] M. Bijak,et al. Oxidative stress parameters as biomarkers of bladder cancer development and progression , 2021, Scientific Reports.
[12] V. Tkachenko,et al. Ischemia-Modified Albumin: Origins and Clinical Implications , 2021, Disease markers.
[13] R. Nishad,et al. Advanced-Glycation End-Products Induce Podocyte Injury and Contribute to Proteinuria , 2021, Frontiers in Medicine.
[14] N. Jha,et al. Oxidative Stress in Cancer Cell Metabolism , 2021, Antioxidants.
[15] S. Georgescu,et al. Posttranslational Modifications Pattern in Clear Cell Renal Cell Carcinoma , 2020, Metabolites.
[16] F. Fazio,et al. Assessment of Total Antioxidant Capacity in Serum of Heathy and Stressed Hens , 2020, Animals : an open access journal from MDPI.
[17] U. Testa,et al. Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic Targets , 2020, Medicines.
[18] K. Tew,et al. Oxidative Stress in Cancer. , 2020, Cancer cell.
[19] A. Mohammed,et al. Epidemiology of Renal Cell Carcinoma , 2020, World journal of oncology.
[20] N. Ferrell,et al. Glycation alters the mechanical behavior of kidney extracellular matrix , 2020, Matrix biology plus.
[21] M. E. Norhaizan,et al. Oxidative Stress, Diet and Prostate Cancer , 2020, The world journal of men's health.
[22] G. Sethi,et al. Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements , 2019, Biomolecules.
[23] Yi Xiao,et al. Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies , 2019, International Journal of Molecular Sciences.
[24] S. Pejić,et al. The effect of antioxidant status on overall survival in renal cell carcinoma , 2019, Archives of medical science : AMS.
[25] Junhua Zheng,et al. Receptors for advanced glycation end products is associated with autophagy in the clear cell renal cell carcinoma , 2019, Journal of cancer research and therapeutics.
[26] F. Bray,et al. Epidemiology of Renal Cell Carcinoma. , 2019, European urology.
[27] A. Gavin,et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. , 2018, European journal of cancer.
[28] D. Harrison,et al. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies , 2018, World Journal of Urology.
[29] M. Vincent,et al. Reactive oxygen species (ROS) are a key determinant of cancer's metabolic phenotype , 2018, International journal of cancer.
[30] A. Merseburger,et al. Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition , 2017, Current opinion in urology.
[31] R. Sahu,et al. Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization , 2017, Integrative cancer therapies.
[32] S. Sahoo,et al. Evaluation of ischemia-modified albumin, oxidative stress, and antioxidant status in acute ischemic stroke patients , 2017, Journal of natural science, biology, and medicine.
[33] P. S. Mahalingaiah,et al. Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells , 2016, Oncotarget.
[34] C. la Vecchia,et al. The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks. , 2016, European urology.
[35] W. Rathmell,et al. Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas , 2016, Molecular Cancer Research.
[36] O. Erel,et al. Evaluation of oxidative stress status and antioxidant capacity in patients with renal cell carcinoma , 2015, Central European journal of urology.
[37] G. Kaushik,et al. Status of oxidative stress in patients with renal cell carcinoma. , 2012, The Journal of urology.
[38] C. Porta,et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[39] T. Simić,et al. Altered antioxidant capacity in human renal cell carcinoma: role of glutathione associated enzymes. , 2008, Urologic oncology.
[40] M. Akıncı,et al. Advanced Oxidation Protein Products, Ferrous Oxidation in Xylenol Orange, and Malondialdehyde Levels in Thyroid Cancer , 2007, Annals of Surgical Oncology.
[41] T. Tammela,et al. Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma , 2006, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[42] M. Gago-Domínguez,et al. Lipid peroxidation and renal cell carcinoma: further supportive evidence and new mechanistic insights. , 2006, Free radical biology & medicine.
[43] T. Tammela,et al. Antioxidant enzymes in renal cell carcinoma. , 2006, Histology and histopathology.
[44] I. Ivanov,et al. Evidence for non‐enzymatic glycosylation of Escherichia coli chromosomal DNA , 2005, Molecular microbiology.
[45] M. Denis,et al. Loss of NOS1 expression in high-grade renal cell carcinoma associated with a shift of NO signalling , 2004, British Journal of Cancer.
[46] D. Bar-Or,et al. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. , 2000, The Journal of emergency medicine.
[47] C. Rice-Evans,et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. , 1999, Free radical biology & medicine.
[48] P. Jungers,et al. Advanced Oxidation Protein Products as Novel Mediators of Inflammation and Monocyte Activation in Chronic Renal Failure1, 2 , 1998, The Journal of Immunology.
[49] P. Jungers,et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. , 1998, Journal of immunology.
[50] J J Strain,et al. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. , 1996, Analytical biochemistry.
[51] P. Metcalf,et al. Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. , 1983, Clinica chimica acta; international journal of clinical chemistry.
[52] G. Ellman,et al. Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.
[53] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[54] Handbook of Oxidative Stress in Cancer: Mechanistic Aspects , 2022 .
[55] C. Pathak,et al. Advanced Glycation End Products Mediated Oxidative Stress and Regulated Cell Death Signaling in Cancer , 2021, Handbook of Oxidative Stress in Cancer: Mechanistic Aspects.
[56] B. Ratliff,et al. Oxidant Mechanisms in Renal Injury and Disease. , 2016, Antioxidants & redox signaling.
[57] Robert Li,et al. Defining ROS in Biology and Medicine. , 2016, Reactive oxygen species.
[58] D. Dash,et al. Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation. , 2013, Aging and disease.
[59] B. Sancak,et al. Serum levels of interleukin-18 and nitrite+nitrate in renal cell carcinoma patients with different tumor stage and grade. , 2004, Neoplasma.
[60] K. Yagi. Assay for blood plasma or serum. , 1984, Methods in enzymology.